Listen Now

Topics Covered

  • Overview of CAR-T Cell Therapy
  • Understanding CARs –Chimeric Antigen Receptors
  • When to Consider CAR-T Cell Therapy as a Treatment Choice
  • Clinical Trials for CAR-T Cell Therapy
  • Discussion of CAR-T Cell Therapy
  • Managing Potential Treatment Side Effects
  • Specific Examples of How CAR-T Cell Therapy Contributes to Oncology Care
  • Key Questions to Ask Your Health Care Team about CAR-T Cell Therapy
  • The Benefits of CAR-T Cell Therapy
  • Follow-Up Care: What to Expect
  • Questions for Our Panel of Experts

Our Panel of Experts

John P. Leonard, MD

Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Associate Dean for Clinical Research, Weill Cornell Medical College, Vice Chairman for Clinical Research, Weill Department of Medicine, Associate Director of Clinical Trials, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, Attending Physician, Chief Lymphoma Service, New York-Presbyterian, Director of the Joint Clinical Trials Office, Weill Cornell Medicine and New York-Presbyterian

Raoul Tibes, MD, PhD

Director, Clinical Leukemia Program, Laura & Isaac Perlmutter Cancer Center, Associate Professor, NYU School of Medicine, Scholar in Clinical Research, Leukemia & Lymphoma Society

Anas Younes, MD

Chief Lymphoma Service, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College

Sattva S. Neelapu, MD

Professor and Deputy Chair ad interim, Director of Laboratory and Translational Research, Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW

Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop(pdf)(80 KB)

Workshop Date

This workshop was originally recorded on June 25, 2018.

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you will learn more about our use of cookies which help us make continuous improvements to our website. Learn more.